Anheuser-Busch InBev SA/NV (BUD) Q3 2024 Earnings Call Transcript Summary
Anheuser-Busch InBev SA/NV (BUD) Q3 2024 Earnings Call Transcript Summary
Organic EBITDA growth resulted in an underlying EPS of $0.98 per share, marking a 14% increase.The following is a summary of the Anheuser-Busch InBev SA/NV (BUD) Q3 2024 Earnings Call Transcript:
以下是百威英博SA/NV（BUD）2024年第三季度業績會議呼叫交易摘要:
Financial Performance:
金融業績：
AB InBev reported a revenue increase of 2.1% this quarter driven by revenue management choices and ongoing premiumization.
EBITDA grew by 7.1% with a margin expansion of 169 basis points.
Organic EBITDA growth resulted in an underlying EPS of $0.98 per share, marking a 14% increase.
本季度，百威英博報告營收增長2.1%，受營收管理選擇和持續高端化的推動。
EBITDA增長了7.1%，毛利率擴大了169個點子。
有機EBITDA增長導致每股收益爲0.98美元，增長14%。
Business Progress:
業務進展：
AB InBev witnessed revenue growth in over 60% of its markets and saw substantial volume share gains from its beer portfolio in the U.S., led by Michelob ULTRA and Busch Light.
Announced a $2 billion share buyback program to be executed over the next 12 months.
Expanding their digital platform BEES, capturing approximately $12.1 billion in gross merchandising value, a 14% increase year-over-year.
百威英博在60%以上的市場實現了營收增長，並從其啤酒組合中在美國獲得了實質性的成交量份額增長，主要由Michelob ULTRA和Busch Light領導。
宣佈了一個價值20億美元的股票回購計劃，將在未來12個月內執行。
擴大他們的數字平台BEES，實現約$121億的總銷售價值，同比增長14%。
Opportunities:
機會：
The non-alcohol beer segment represented by Corona Cero saw volumes and revenues more than doubling, evidencing significant market share gains.
Premium and super premium brands delivered growth, accounting for about 57% of revenue in certain markets.
由科羅娜零度代表的無酒精啤酒部門的成交量和營業收入均翻了一番，表明市場份額大幅增長。
高端和超高端品牌帶來增長，佔某些市場營業收入的約57%。
Risks:
風險：
Volume declines due to soft consumer environments in China and Argentina, with an overall volume decline of 2.4%.
Adverse weather and economic slowdowns impacted operations in Middle Americas.
由於中國和阿根廷消費環境疲軟，導致成交量下降，整體成交量下降2.4%。
逆境天氣和經濟放緩影響了中美洲的業務運營。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
